Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × Alpelisib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Neoplasm Metastasis 3 Recurrence 2 Ovarian Neoplasms 2 Lymphatic Abnormalities 2 Lymphangioma, Cystic 2 Lymphangioma 2 Hereditary Sensory and Autonomic Neuropathies 2 Vascular Malformations 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases, Vascular 1 Hyperglycemia 1 Hormone Receptor Positive Breast Carcinoma 1 Head and Neck Squamous Cell Cancer 1 Head and Neck Neoplasms 1 HER2-positive Metastatic Breast Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Arteriovenous Malformations 1 Advanced HER2+Breast Cancer 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 11 Cisplatin 9 Carboplatin 9 Paclitaxel 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 4 cemiplimab 3 Radiation 3 Docetaxel 3 Blood Specimen Collection 3 alpha-2'-deoxythioguanosine 2 Taxes 2 Standard of Care 2 Nivolumab 2 Drug Therapy 2 toripalimab 1 regorafenib 1 olaparib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 bavituximab 1 avelumab 1 atezolizumab 1 aldesleukin 1 aflibercept 1 Vitamin D 1 Vinorelbine 1 Tumor Burden 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡